Comparative antianaerobic activity of BMS 284756

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 2, 2001, Pages 589-592

  Hoellman, D B ^a   Kelly, L M ^a   Jacobs, M R ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLINDAMYCIN; GARENOXACIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTERIA, ANAEROBIC; BETA-LACTAMASES; CLAVULANIC ACID; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; FLUOROQUINOLONES; INDOLES; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0035142036     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.2.589-592.2001     Document Type: Article

References (16)

1. Characterization of β-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in β-lactam resistance
2. Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium
3. β-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides and 129 fusobacteria from 28 U.S. centers
4. Susceptibility of 539 gram-positive and -negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam
5. Characterization of a β-lactamase from Clostridium clostridioforme
6. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin
7. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin
8. Comparative in vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990
9. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
10. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms
11. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and Win 57273 against anaerobic bacteria
12. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. Approved standard. NCCLS publication no. M11-A3
13. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes
14. Wadsworth anaerobic bacteriology manual, 5th ed.
15. In vitro and in vivo antimicrobial activities of T-3811ME, a novel Des-F(6)-quinolone
16. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria